Garuda Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$50M

Garuda Therapeutics develops proprietary hematopoietic stem cell therapies that are self-renewing, HLA-compatible, and transgene-free for immediate patient availability.